Ungass Country Progress Report Thailand Reporting Period January 2008-December 2009.http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmittedbycountries/thailand_2010_country_progress_report_en.pdf
Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, Suebsaeng L, Lo YR: The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health. 2006, 37: 704-15.
PubMed
Google Scholar
Kiertiburanakul S, Khongnorasat S, Rattanasiri S, Sungkanuparph S: Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients. J Med Assoc Thai. 2007, 90: 237-43.
PubMed
Google Scholar
Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ. 1999, 160: 659-65.
PubMed Central
CAS
PubMed
Google Scholar
Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD: Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998, 352: 1725-30. 10.1016/S0140-6736(98)03201-2
Article
CAS
PubMed
Google Scholar
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998, 338: 853-60. 10.1056/NEJM199803263381301
Article
PubMed
Google Scholar
Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS: Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ. 1999, 160: 659-65.
PubMed Central
CAS
PubMed
Google Scholar
Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K: Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience. AIDS. 2007, 21 (Suppl 4): S47-53. 10.1097/01.aids.0000279706.24428.78
Article
PubMed
Google Scholar
Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KA: Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007, 44: 30-7. 10.1097/01.qai.0000248351.10383.b7
Article
PubMed Central
PubMed
Google Scholar
Tuboi SH, Harrison LH, Sprinz E, Albernaz RK, Schechter M: Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil. J Acquir Immune Defic Syndr. 2005, 40: 324-8. 10.1097/01.qai.0000182627.28595.01
Article
PubMed
Google Scholar
Anekthananon T, Ratanasuwan W, Techasathit W, Sonjai A, Suwanagool S: Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study. J Med Assoc Thai. 2004, 87: 760-7.
PubMed
Google Scholar
Kozal MJ, Hullsiek KH, Macarthur RD, Berg-Wolf M, Peng G, Xiang Y, Baxter JD, Uy J, Telzak EE, Novak RM: The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naive participants started on three different antiretroviral therapy strategies. HIV Clin Trials. 2007, 8: 357-70. 10.1310/hct0806-357
Article
PubMed
Google Scholar
Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG: Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment. HIV Med. 2007, 8: 46-54. 10.1111/j.1468-1293.2007.00427.x
Article
CAS
PubMed
Google Scholar
Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, Downing R, Mermin J, Weidle PJ: Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr. 2005, 38: 578-83. 10.1097/01.qai.0000134742.26338.2f
Article
PubMed
Google Scholar
Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M: CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med. 2003, 163: 2187-95. 10.1001/archinte.163.18.2187
Article
PubMed
Google Scholar
Moore RD, Keruly JC: CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007, 44: 441-6. 10.1086/510746
Article
PubMed
Google Scholar
Parienti JJ, Massari V, Descamps D, Vabret A, Bouvet E, Larouze B, Verdon R: Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004, 38: 1311-6. 10.1086/383572
Article
CAS
PubMed
Google Scholar
Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, Vecchiet J, D'Arminio Monforte A, Wu AW, Antinori A: Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S123-7.
Article
PubMed
Google Scholar
McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP: Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis. 2001, 33: 700-5. 10.1086/322590
Article
CAS
PubMed
Google Scholar
Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, Bellocchi MC, Trotta MP, Piano P, Forbici F, Scasso A, Vullo V, d'Arminio Monforte A, Antinori A: Virologic correlates of adherence to antiretroviral medications and therapeutic failure. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S118-22.
Article
PubMed
Google Scholar
Turner BJ: Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis. 2002, 185 (Suppl 2): S143-51.
Article
PubMed
Google Scholar
Lucas GM, Chaisson RE, Moore RD: Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999, 131: 81-7.
Article
CAS
PubMed
Google Scholar
Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC: Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006, 41: 385-92. 10.1097/01.qai.0000186371.95301.52
Article
PubMed
Google Scholar
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 2009, 1-161.http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R, Aiuti F: Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS. 1999, 13: 1187-93. 10.1097/00002030-199907090-00006
Article
CAS
PubMed
Google Scholar
Aiuti F, Mezzaroma I: Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev. 2006, 8: 88-97.
PubMed
Google Scholar
Lawn SD, Myer L, Bekker LG, Wood R: CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis. 2006, 6: 59- 10.1186/1471-2334-6-59
Article
PubMed Central
PubMed
Google Scholar
Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN: Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003, 17: 1907-15. 10.1097/00002030-200309050-00009
Article
PubMed
Google Scholar
Braitstein P, Zala C, Yip B, Brinkhof MW, Moore D, Hogg RS, Montaner JS: Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program. J Infect Dis. 2006, 193: 259-68. 10.1086/498908
Article
CAS
PubMed
Google Scholar
Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ: Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS. 2004, 18: 1169-77. 10.1097/00002030-200405210-00010
Article
PubMed
Google Scholar